Investigating the Prevalence of Gestational Diabetes Mellitus and Its Related Factors in Women Referred To Shahroud Medical- Research Centers
DOI:
https://doi.org/10.61841/b66acg82Keywords:
Gestational diabetes mellitus, type 2 diabetes, gestational age, first-degree relatives, ShahroudAbstract
Objective: Considering the importance of gestational diabetes mellitus and different reports on the prevalence and risk factors of this disease, this research was conducted among pregnant mothers referred to Shahrood health centers in 2013 to determine the prevalence and risk factors of gestational diabetes mellitus and glucose tolerance disorder.
Method: This is a cross-sectional descriptive-analytical study. The study population was pregnant women who referred to clinics (health centers) in Shahroud for controlling pregnancy. The sample size was estimated at 1000 people. In order to screen for gestational diabetes at 24-28 weeks, all 1000 samples with normal blood glucose at first visit were asked a two-hour oral glucose tolerance test with consuming 75 g glucose (OGTT). Descriptive statistics (frequency, percentage and mean) and inferential statistics (t-test) were used for data analysis by SPSS software.
Results: The prevalence of gestational diabetes was 3.8%. Another result was that increasing age increased the risk of gestational diabetes and its subsequent complications. Another point is the relationship between the history of gestational diabetes and type 2 diabetes in relatives and the incidence of gestational diabetes.
Conclusion: The results of this study can be considered as an alarm signal for increasing the age of the pregnancy. A pregnant woman with a history of gestational diabetes or type 2 diabetes in her first-degree relatives should know that she has a higher risk of developing gestational diabetes. These can be adjusted by appropriate diet and exercise that can reduce the risk of diabetes during pregnancy and protect the mother and fetus from complications of gestational diabetes.
Downloads
References
[1]. Azizi F., Hatami H., Janghorbani M (2009). Epidemilogy of common disorder in Iran (Persion). 2en ed. Tehran: Eshtiagh. 32.
[2]. Roglic G., Unwin N., Bennett PH., Mathers C., Tuomilehto J., Nag S., et al. (2008). The burden of mortality attributable to diabetes: realistic estimates for the year burden of mortality attributable to diabetes; realistic estimates for the year 2000. Diabetes Care. 28 (9).2130-50.
[3]. Power AC. (2007). Diabetes mellitus. In: Kasper Dl, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL. Harrison principle of internal medicine. 16 th ed. 2273-7.
[4]. Manafi M., Ansari MH, Rabieepour S., Hazhir MS. (2003). Prevalence of Gestational Diabetes in pregnant women attended uremia health centers. Uremia Med J. 19 (2). 158-62.
[5]. Meltzer S., Heiter, Daneman D., Gerstein HC., Lau D., Ludwig S. (2009).Clinical practice guidelines for the management of diabetes in Cabada. CMAJ. 159;29-1.
[6]. 6-Gunningham FG., Gant NF., Leveno KJ., Gilstrap LC., Hauth JC.Wenstrom KD. (2001).Williams Obstetrics. 21st ed. New York. McGraw Hill.
[7]. American Diabetse Association. (2011). Position Statement. Gestational diabetes mellitus. Diabetes Care. 27: 88-90.
[8]. Hosseinnezhad A., Larigani B. (2001). Cost Analisis of screening and diagnostic in gestational diabete. Iran J Diabetes Lipid Disord. 1(1) : 31-40.
[9]. Benjamin E., Winters D., Mayfield J., Gohdes D. (2010).Diabetes in pregnancy in Zuni Indian women. Prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care. 16: 1231-1235.
[10]. Dornhorst A., Patterson CM., Nicholls JS., Wadsworth J., Chiu DC., Elkeles RS. (2009). High prevalence of gestational diabetes in women from ethnic groups. Diabetes Med. 9: 820-825.
[11]. Larigani B. (1999). Diabetes and Pregnancy. 1 st ed. Tehran: publications of the foundation for special Diseases.
[12]. Cunningham FG, Williams JW, Leveno KJ, Bloom S., Hauth JC. (2009). Williams Obstetrics.
23rd ed. New York, NY: McGraw-Hill Medical.
[13]. Kashi Z., Borzouei SH., Akhi A., Moslemzadeh N., Zakeri HR, Mohammad pour Tahmtan R., et al. (2010).Diagnostic value of fasting plasma glucose in screening of gestational diabetes mellitus. Iran J Diabetes Lipid Disord; 6 (1): 67-72.
[14]. Eshraghian M., Larigani B., Naghaie F., Pajouhi M., Alimohamadian M., Sajadi S.A. (2003).Identification of risk factors of gestational diabetes and their impact of Iranian pregnant women. J Med Counc I R Iran. 17 (3): 239-44.
[15]. Larigani B., Azizi F., Pazhoui M., Bastanhagh MH., Marsusi V., Hosseinnezhad A. (2009). The prevalence of gestational diabetes in pregnant women referred to hospital affiliated to Tehran university of Medical Science. Iran J Endocrinal Metab. 1(2); 125-33.
[16]. Larijani, Bagher & Azizi, Fereydoon & Pazhouhi, Mohammad et al. (2008). Prevalence of gestational diabetes mellitus in pregnant women referred to hospitals of Tehran University of Medical Sciences. Iranian Journal of Endocrinology and Metabolism. Vol. 1, No. 2, 125-133.
[17]. Keshavarz M. Cheung NW., Babaee GR. (2005).Gestational diabetes in Iran: Incidence, risk factors and pregnancy outcomes. Diabetes Ren clin Pract. 6: 279-286.
[18]. Tabatabei AS., Fallah Z., Haghighi S., Farmani M.,Horri N., Eslamian Z. (2007). Prevalence and risk factors for gestational Diabetes Mellitus in pregnant women of Isfahan. Iran J Endocrinal Metab. 9(3): 251-9.
[19]. Atashzadeh shooride F. (2012). Frequency of Gestational Diabetes and its Related Factors in pregnant Women in prenatal Clinics of Educational Hospitals. In Tehran. JRafsanjan Univ Med Sci, 5 (3); 175-80.
[20]. Karimi F., Nabipour I., Jafari M., Gholamzadeh F. (2002).Selective Screening for gestational diabetes in Bushehr, based on a 50 gram glucose challenge test. Iran J Diabetees Lipid Disord. 2(1):45-52.
[21]. Mirfeyzi M., Azarban AA., Mirheidari M. (2010). Analysis of the prevalence of Gestational diabetes and risk factors in pregnant women karaj. Iran JDiabetes Lipid Disord; 9 (4): 107-15.
[22]. Ataei, M., Jalilvand, F., Hashemnejad, M., (2018), Successful management of non-diagnosed placenta percreta during dilatation & extraction surgery, International Journal of Pharmaceutical Research, 10(4), pp. 879-881.
[23]. Farahani, M., Mashak, B., Ataei, M., (2018), A rare case of broad ligament hematoma after normal vaginal delivery, International Journal of Pharmaceutical Research, 10(4), pp. 834-837.
[24]. Ehsan Z, Yazdkhasti M, Rahimzadeh M, Ataee M, Esmaelzadeh-Saeieh S. Effects of Group Counseling on Stress and Gender-Role Attitudes in Infertile Women: A Clinical Trial. J Reprod Infertil. 2019;20(3):169-177, http://www.jri.ir/article/30042
[25]. Modarresi M , Mehdizadehkashi A, Chaichian S, Ataei M , Ahmadi-Pishkuhi M. Sonographic Assessment of Ovarian Endometrioma Recurrence Six Months After Laparoscopic Cystectomy in Patients with Endometriosis, Shiraz E-Med J. Online ahead of Print ; In Press(In Press):e92163. doi: 10.5812/semj.92163, http://emedicalj.com/en/articles/92163.html
[26]. Masoumeh Farahani, Banafsheh Mashak, Mina Ataei, A Rare Case of Broad Ligament Hematoma after Normal Vaginal Delivery, International Journal of Pharmaceutical Research, Oct- Dec 2018, Vol 10, Issue 04, pp. 834-837, http://ijpronline.com/ViewArticleDetail.aspx?ID=7338.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
